Royalty Pharma plc
RPRX
株式のランク
#867
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a... Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.
株価
$62.21
時価総額
$27.70B
変化（1日）
3.22%
変化（1年）
69.83%
国
US
取引 Royalty Pharma plc (RPRX)
カテゴリー
Healthcare
Royalty Pharma plc（RPRX）の利益
Jun 2026 時点の利益 TTM: $1.35B
Royalty Pharma plc の最新の財務報告によると、同社の現在の利益は $1.35B です。2024 年には $1.33B の利益を上げ、これは 2023 年の利益 $1.70B と 減少 です。このページに表示されている利益は、利息および税引き前利益、すなわち EBIT です。
Royalty Pharma plc の利益の推移（2015 〜 2026）
各年末の利益
| 年 | 利益 | 変化 |
|---|---|---|
| 2026 (TTM) | $1.35B | 1.94% |
| 2025 | $1.32B | -0.50% |
| 2024 | $1.33B | -21.72% |
| 2023 | $1.70B | 638.96% |
| 2022 | $230.06M | -81.46% |
| 2021 | $1.24B | -27.07% |
| 2020 | $1.70B | -30.85% |
| 2019 | $2.46B | 62.16% |
| 2018 | $1.52B | 13.00% |
| 2017 | $1.34B | 76.29% |
| 2016 | $761.90M | 0.42% |
| 2015 | $758.71M | 0.00% |
同業他社の利益
| 企業 | 利益 | 利益の差 | 国 |
|---|---|---|---|
| - | - |
SE
|
|
| - | - |
FR
|
|
| - | - |
IT
|
|
| $26.37M | -98.05% |
US
|
|
| $1.21B | -10.73% |
HK
|
